The scientist’s investigation covers issues in Antibody, Virology, Molecular biology, Cytidine deaminase and Immunoglobulin class switching. Her Antibody study is concerned with Immunology in general. Her Virology research incorporates elements of Germline mutation, Heterologous, Germline and Priming, Antigen.
Her research in Molecular biology intersects with topics in Non-homologous end joining, DNA, DNA repair and Activation-induced deaminase. The concepts of her DNA study are interwoven with issues in Mutation and Gene. Her Activation-induced deaminase study integrates concerns from other disciplines, such as Immunoglobulin gene, microRNA and Chromosomal translocation.
Her scientific interests lie mostly in Antibody, Virology, Monoclonal antibody, Virus and Immunology. Anna Gazumyan combines subjects such as Immunity and Antigen with her study of Antibody. The study incorporates disciplines such as Epitope, Serology, Potency and In vivo in addition to Virology.
Her research integrates issues of Mutation and Heterologous in her study of Immunology. Her Mutation research is multidisciplinary, relying on both Cytidine deaminase and Immunoglobulin class switching. She works mostly in the field of Immunoglobulin class switching, limiting it down to topics relating to Immunoglobulin gene and, in certain cases, Activation-induced deaminase, as a part of the same area of interest.
Her main research concerns Antibody, Virology, Monoclonal antibody, Virus and Neutralization. Her Antibody study contributes to a more complete understanding of Immunology. Her biological study spans a wide range of topics, including Epitope, Serology and In vivo.
Her Epitope research includes elements of HBsAg and Hepatitis B virus. Her work deals with themes such as Recombinant DNA and Vaccination, which intersect with Monoclonal antibody. Her Antigen research includes themes of Germinal center, Immune system and Cell biology.
Her primary scientific interests are in Antibody, Virology, Virus, Monoclonal antibody and Neutralization. Her Antibody research is included under the broader classification of Immunology. Anna Gazumyan has included themes like In vivo and Effector in her Virology study.
Her Monoclonal antibody research is multidisciplinary, incorporating perspectives in In vitro, Potency, Serology and Vaccination. Her work deals with themes such as Vesicular stomatitis virus and Neutralizing antibody, which intersect with Neutralization. As a part of the same scientific family, Anna Gazumyan mostly works in the field of Recombinant DNA, focusing on Titer and, on occasion, Immunization.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Convergent antibody responses to SARS-CoV-2 in convalescent individuals.
Davide F. Robbiani;Davide F. Robbiani;Christian Gaebler;Frauke Muecksch;Julio C.C. Lorenzi.
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Yiska Weisblum;Fabian Schmidt;Fengwen Zhang;Justin DaSilva.
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Zijun Wang;Fabian Schmidt;Yiska Weisblum;Frauke Muecksch.
Evolution of antibody immunity to SARS-CoV-2.
Christian Gaebler;Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch.
MicroRNA-155 Suppresses Activation-Induced Cytidine Deaminase-Mediated Myc-Igh Translocation
Yair Dorsett;Kevin M. McBride;Mila Jankovic;Anna Gazumyan;Anna Gazumyan.
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
Fabian Schmidt;Yiska Weisblum;Frauke Muecksch;Hans-Heinrich Hoffmann.
Journal of Experimental Medicine (2020)
Activation-Induced Cytidine Deaminase Targets DNA at Sites of RNA Polymerase II Stalling by Interaction with Spt5
Rushad Pavri;Anna Gazumyan;Anna Gazumyan;Mila Jankovic;Michela Di Virgilio.
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg;Ching-Lan Lu;Florian Klein;Joshua A. Horwitz.
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
Masashi Shingai;Olivia K. Donau;Ronald J. Plishka;Alicia Buckler-White.
Journal of Experimental Medicine (2014)
Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Ching-Lan Lu;Ching-Lan Lu;Dariusz K. Murakowski;Stylianos Bournazos;Till Schoofs.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: